Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from the SFGM-TC-Reference-Cited by-同舟云学术

Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from the SFGM-TC

Published:2012-02 Issue:2 Volume:18 Page:250-256
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bay J.O.,Cabrespine A.,Faucher C.,Tabrizi R.,Bordigoni P.,Berceanu A.,Coiteux V.,Renaud M.,Mialou V.,Robin M.,Kuentz M.,Chevallier P.,Dhédin N.,Huynh A.,Garban F.,Witz F.,Buzyn A.,De Revel T.,Galambrun C.,Deconinck E.,Contentin N.,François S.,Gratecos N.,Blaise D.,Michallet M.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference25 articles.

1. Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial

2. Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol;Moreau;Blood,2006

3. Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma;Garban;Blood,2006

4. Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant;Shaw;Bone Marrow Transplant,2008

5. Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft;Gaziev;Bone Marrow Transplant,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation;HemaSphere;2024-03

2. Salvage haploidentical or cord‐blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM‐TC;European Journal of Haematology;2022-10-17

3. Outcomes of second hematopoietic stem cell transplantation using reduced‐intensity conditioning in an outpatient setting;Hematological Oncology;2020-10-03

4. Seconde allogreffe : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC);Bulletin du Cancer;2019-01

5. Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect;Experimental Hematology;2017-04